Oncology Services (OS) is a leading, internationally operating CRO with unmatched expertise and extensive experience in oncology drug development and study management.
With operations in Europe and India, OS provides end-to-end solutions for drug development, including services of Phase I to IV, regulatory affairs, consulting for drug development, medical writing, data management and statistics, quality assurance and pharmacovigilance.
With oncology emerging as a therapeutic field that demands exclusive focus, intensive efforts and expertise for successful drug development, Oncology Services (OS) offers efficient clinical study execution by bringing to bear all of these essentials.
With a history of more than 150 clinical trials, Oncology Services has comprehensive expertise in all major oncology indications, and experience in managing all the phases of clinical trials with more than 6,500 patients.
A vast experience in the field has enabled OS to evolve a thorough knowledge of patient population and disease profile in oncology, significantly enhancing the recruitment process.
Its well-developed network of clinical investigators ensures swift completion of study enrolment - a key issue in achieving successful study management.
With extensive devotion to oncology drug trials over the years, Oncology Services' performance in oncology clinical trials has made it a trusted and preferred partner for some of the world's leading oncology research companies.
Over the years, OS has been able to win the confidence of its clients thanks to its work ethic, which places special emphasis on client-CRO synergy, which in turn ensures the service provider becomes an extension of the client's drug development team.
Another key aspect that results in successful study management is its proactive risk analysis and contingency planning.
With these distinctive features, Oncology Services has marked a victory in terms of timely and efficacious completion of projects, which is the primary stipulation in anti-cancer drug development.